Dongsung Pharmaceutical Co logo

Dongsung Pharmaceutical Co

UpGuard continuously monitors the security posture of Dongsung Pharmaceutical Co using open-source, commercial, and proprietary threat intelligence feeds. Our analysis is centered on objective, externally verifiable information.

Get the full report

Dongsung Pharmaceutical Co Security Rating

Dongsung Pharmaceutical Co's security rating is based on the analysis of their external attack surface. The higher the rating, the better their security posture. Start a free trial to get a more in-depth risk assessment for Dongsung Pharmaceutical Co.

Company Dongsung Pharmaceutical Co Employees 5 Location Korea, Republic of Last updated August 26, 2026

Last updated August 26, 2026

Dongsung Pharmaceutical Co Vendor Risk Report

This vendor risk report is based on UpGuard's continuous monitoring of Dongsung Pharmaceutical Co's security posture using open-source, commercial, and proprietary threat intelligence feeds. The results are summarized into a security rating based on the analysis of hundreds of individual checks across five risk categories: website security, email security, phishing & malware, brand & reputation risk, and network security.

Get the full report

X-Frame-Options is not deny or sameorigin

Browsers may display this website's content in frames. This can lead to clickjacking attacks.

CSP is not implemented

No valid Content Security Policy is implemented. This increases the risk of XSS and clickjacking attacks.

X-Content-Type-Options is not nosniff

Browsers may interpret files as a different MIME type than what is specified in the Content-Type HTTP header. This can lead to MIME confusion attacks.

Server information header not exposed

Ensuring the server information header is not exposed reduces the ability of attackers to exploit certain vulnerabilities.

X-Powered-By header not exposed

Information about specific technology used on the server is obscured.

Referrer policy is not unsafe-url

The website's Referrer Policy is not configured to allow unsafe information to be sent in the referrer header.

ASP.NET version header not exposing specific ASP.net version

Ensuring the ASP.NET version header is not exposing a specific version makes it harder for attackers to exploit certain vulnerabilities.

ASP.NET version header not exposed

Ensuring the ASP.NET version header is not exposed makes it harder for attackers to exploit certain vulnerabilities.

No unmaintained page detected

The page appears to be maintained.

Free · for Dongsung Pharmaceutical Co customers & vendors

You're evaluating Dongsung Pharmaceutical Co's risk.Are attackers evaluating yours?

UpGuard runs 330+ external checks on Dongsung Pharmaceutical Co continuously. Get the same view of your own company — free, in 30 seconds.
Website Security scan results table Cyber security rating score 850 out of 950

DNSSEC not enabled

DNSSEC records prevent third parties from forging the records that guarantee a domain's identity. DNSSEC should be configured for this domain.

No subdomain takeover vulnerability detected

No dangling DNS records that could lead to subdomain takeover were detected.

SSL not available

SSL is the standard encryption method for browsing websites. Enabling SSL requires installing an SSL certificate on the site.

HTTP requests are redirected to HTTPS

All HTTP requests are redirected to HTTPS.

No open cloud storage service detected

No cloud storage service configured to allow anonymous file listing was detected.

Domain index is not a listable directory

The domain index is not a listable directory.

Not a suspected malware provider

This website does not appear to contain malicious code.

No reports of botnet activity in the last 30 days

This IP/domain has not been reported as a source of botnet activity in the last 30 days.

No reports of brute force login attempts in the last 30 days

This IP/domain did not appear on any list of IPs and domains known to perform brute force login attempts in the last 30 days.

No reports of malware distribution in the last 30 days

This IP/domain has been reported for distributing malware in the last 30 days.

No reports of unsolicited scanning in the last 30 days

This IP/domain has not been reported for performing unsolicited scanning in the last 30 days.

Not suspected of unwanted software

This website does not appear to be attempting to install unwanted software.

Not a suspected phishing page

This site does not appear to be a forgery or imitation of another website.

No reports of phishing activity in the last 30 days

This IP/domain has not been reported as a phishing site in the last 30 days.

No reports of botnet activity in the last 90 days

This IP/domain has not been reported as a source of botnet activity in the last 90 days.

No reports of brute force login attempts in the last 90 days

This IP/domain did not appear on any list of IPs and domains known to perform brute force login attempts in the last 90 days.

No reports of malware distribution in the last 90 days

This IP/domain has been reported for distributing malware in the last 90 days.

No reports of unsolicited scanning in the last 90 days

This IP/domain has not been reported for performing unsolicited scanning in the last 90 days.

No reports of phishing activity in the last 90 days

This IP/domain has not been reported as a phishing site in the last 90 days.

Security reports related to Dongsung Pharmaceutical Co

Compare Dongsung Pharmaceutical Co's security performance with other companies in their industry.

Cybersecurity & Risk Management Library

The ultimate guide to attack surface and third-party risk management – actionable advice for security teams, managers, and executives.

Free · for Dongsung Pharmaceutical Co customers & vendors

You're evaluating Dongsung Pharmaceutical Co's risk.Are attackers evaluating yours?

UpGuard runs 330+ external checks on Dongsung Pharmaceutical Co continuously. Get the same view of your own company — free, in 30 seconds.
Website Security scan results table Cyber security rating score 850 out of 950
View our Security Reports Policy.